LigaChem Biosciences

141080.KQ

76.10 USD

3.22

+4.42%

Overview

Last close

76.10 usd

Market cap

2.76B usd

52 week high

99.94 usd

52 week low

33.77 usd

Target price

109.11 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

30.5765

Price/Book Value

6.1962

Enterprise Value

2.32B usd

EV/Revenue

26.4002

EV/EBITDA

227.0752

Key financials

Revenue TTM

87.81M usd

Gross Profit TTM

76.69M usd

EBITDA TTM

-11.09M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

500.95M usd

Net debt

N/A usd

About

LigaChem Biosciences Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It also sells medical device and supplies. It has a research collaboration and license agreement with AMGEN for the development and commercialization of ADCs. The company was formerly known as LegoChem Biosciences, Inc. and changed its name to LigaChem Biosciences Inc. in April 2024. LigaChem Biosciences Inc. was founded in 2006 and is headquartered in Daejeon, South Korea.